Clinical Trial Update: Functional Imaging of T-Cell Activation With [18F]F-AraG in Urothelial Carcinoma Patients Receiving Neoadjuvant Therapy or Patients With Cancer Receiving Standard of Care Anti-PD-1/L1 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating imaging of T-cell activation using [18F]F-AraG in urothelial carcinoma patients receiving neoadjuvant therapy or anti-PD-1/PD-L1 therap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Carcinoma

Snippet

Sponsor: Lawrence Fong | Conditions: Bladder Cancer | Phase 2 | Status: TERMINATED | Results posted: 2020-01-21